SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.369
AS - Asia 17.175
EU - Europa 9.796
SA - Sud America 2.631
AF - Africa 364
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 16
Totale 65.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.729
SG - Singapore 6.505
CN - Cina 4.199
BR - Brasile 2.017
DE - Germania 1.860
IT - Italia 1.841
VN - Vietnam 1.811
UA - Ucraina 1.707
HK - Hong Kong 1.453
GB - Regno Unito 1.075
TR - Turchia 969
FI - Finlandia 764
FR - Francia 618
BD - Bangladesh 598
SE - Svezia 468
RU - Federazione Russa 428
JP - Giappone 378
PL - Polonia 367
CA - Canada 329
IN - India 319
MX - Messico 226
AR - Argentina 199
ID - Indonesia 174
ZA - Sudafrica 137
NL - Olanda 131
IQ - Iraq 123
BE - Belgio 106
PK - Pakistan 105
CO - Colombia 97
EC - Ecuador 97
ES - Italia 86
PH - Filippine 74
SA - Arabia Saudita 61
LT - Lituania 60
AT - Austria 58
UZ - Uzbekistan 58
VE - Venezuela 58
MY - Malesia 53
MA - Marocco 52
CL - Cile 48
PY - Paraguay 42
TN - Tunisia 37
AE - Emirati Arabi Uniti 32
IE - Irlanda 32
CZ - Repubblica Ceca 31
JO - Giordania 31
KR - Corea 31
IR - Iran 30
PE - Perù 27
EG - Egitto 26
KE - Kenya 25
UY - Uruguay 24
IL - Israele 22
NO - Norvegia 21
AL - Albania 19
AZ - Azerbaigian 19
CH - Svizzera 18
DZ - Algeria 18
RO - Romania 18
AU - Australia 17
LB - Libano 17
NP - Nepal 17
BO - Bolivia 16
ET - Etiopia 16
JM - Giamaica 16
GR - Grecia 13
TH - Thailandia 12
KZ - Kazakistan 11
BG - Bulgaria 10
MD - Moldavia 10
NZ - Nuova Zelanda 10
PT - Portogallo 10
SN - Senegal 10
TW - Taiwan 10
BH - Bahrain 9
HN - Honduras 9
PA - Panama 9
DO - Repubblica Dominicana 8
EU - Europa 8
NI - Nicaragua 8
LV - Lettonia 7
NG - Nigeria 7
TT - Trinidad e Tobago 7
KG - Kirghizistan 6
OM - Oman 6
PS - Palestinian Territory 6
SV - El Salvador 6
CI - Costa d'Avorio 5
CR - Costa Rica 5
GE - Georgia 5
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
RS - Serbia 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BJ - Benin 4
DK - Danimarca 4
GY - Guiana 4
KH - Cambogia 4
Totale 65.292
Salva come PNG Salva come JPEG
Città #
Singapore 4.058
Ashburn 3.947
Fairfield 3.529
Woodbridge 3.262
Houston 2.144
San Jose 2.038
Jacksonville 1.846
Ann Arbor 1.682
Chandler 1.529
Hong Kong 1.426
Seattle 1.423
Beijing 1.310
Santa Clara 1.299
Wilmington 1.259
Cambridge 1.191
Ho Chi Minh City 648
Izmir 546
Munich 546
Los Angeles 531
New York 504
Dallas 498
Nanjing 493
Ferrara 467
Princeton 405
Hanoi 392
Lauterbourg 357
Tokyo 352
Warsaw 316
San Diego 314
Boardman 309
Milan 283
Helsinki 273
São Paulo 215
Falkenstein 195
Shanghai 192
Shenyang 154
Hefei 153
Nanchang 153
Council Bluffs 150
Dearborn 146
London 133
Mexico City 133
Falls Church 125
Turku 123
Tianjin 117
Orem 116
San Mateo 114
Buffalo 112
The Dalles 106
Brooklyn 100
Jakarta 100
Frankfurt am Main 98
Brussels 97
Jiaxing 96
Chicago 90
Moscow 90
Atlanta 89
Da Nang 86
Toronto 86
Addison 84
Hebei 84
Changsha 83
Johannesburg 82
Montreal 82
Mountain View 82
Bologna 81
Redwood City 77
Haiphong 75
Bremen 74
Porto Alegre 74
Norwalk 73
San Francisco 73
Denver 71
Rio de Janeiro 67
Washington 65
Stockholm 64
Jinan 62
Philadelphia 59
Phoenix 56
Chennai 54
Guangzhou 54
Zhengzhou 53
Auburn Hills 51
Tashkent 50
Belo Horizonte 48
Boston 46
Columbus 46
Kunming 45
Poplar 45
Baghdad 43
Manchester 43
Rome 40
Amsterdam 39
Biên Hòa 39
Lahore 39
Brasília 38
Dhaka 38
Medellín 36
Curitiba 35
Montréal 35
Totale 44.931
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 404
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 394
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 337
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 334
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 293
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 290
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 289
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 289
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 276
A new selective antagonist of the nociceptin receptor 273
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 272
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 269
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 263
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 259
Designing artificial metalloenzymes exploiting the Spy technology: study of a Cu(II)-Spy construct and perspectives 258
A new ligand for the urotensin II receptor 254
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 253
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 251
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 247
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 244
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 243
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 243
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 242
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 241
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 240
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 239
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 239
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 239
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 235
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 235
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 235
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 234
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 233
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 232
Cardiovascular effects of nociceptin in unanesthetized mice 231
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 231
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 230
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 230
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 229
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 228
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 228
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 226
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 224
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 224
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 224
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 224
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 222
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 220
Physicochemical stability of cabazitaxel and docetaxel solutions 220
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 218
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 217
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 216
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 216
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 215
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 215
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 215
Pharmacological characterization of tachykinin tetrabranched derivatives 215
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 213
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 212
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 212
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 211
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 210
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 208
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 208
Neuropeptide S receptor ligands: a patent review (2005-2016) 207
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 206
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 205
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 205
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 204
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 204
Pharmacological characterization of nociceptin receptor: an in vitro study 204
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 203
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 202
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 202
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 201
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 201
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 201
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 201
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 200
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 200
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 199
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 199
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 198
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 197
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 196
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 196
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 196
Structure-activity study at positions 3 and 4 of human neuropeptide S. 195
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 194
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 194
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 193
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 193
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 191
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 191
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 191
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 190
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 190
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 190
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 190
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 190
Totale 22.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 294.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.527
Totale 297.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 0 0 0 0 0 0 0 0 306
2021/20224.133 164 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.859 417 165 123 473 635 534 194 379 543 21 225 150
2023/20241.915 224 248 114 49 110 296 73 176 41 39 62 483
2024/20258.352 213 185 726 258 995 735 244 608 1.350 842 1.163 1.033
2025/202623.921 2.381 982 2.120 3.012 3.186 1.538 2.855 1.293 2.178 2.652 1.172 552
Totale 65.968